PURPOSE: Studies have noted a link between radiation dose to the heart and overall survival (OS) for patients with lung cancer treated with chemoradiation. The purpose of this study was to characterize pre- to posttreatment cardiac metabolic changes using fluorodeoxyglucose/positron emission tomography (FDG-PET) images and to evaluate whether changes in cardiac metabolism predict for OS. METHODS AND MATERIALS: Thirty-nine patients enrolled in a functional avoidance prospective study who had undergone pre- and postchemoradiation FDG-PET imaging were evaluated. For each patient, the pretreatment and posttreatment PET/CTs were rigidly registered to the planning CT, dose, and structure set. PET-based metabolic dose-response was assessed by comparing pretreatment to posttreatment mean standardized uptake values (SUVmean) in the heart as a function of dose-bin. OS analysis was performed by comparing SUVmean changes for patients who were alive or had died at last follow-up and by using a multivariate model to assess whether pre- to posttreatment SUVmean changes were a predictor of OS. RESULTS: The dose-response curve revealed increasing changes in SUV as a function of cardiac dose with an average SUVmean increase of 1.7% per 10 Gy. Patients were followed for a median of 437 days (range, 201-1131 days). SUVmean change was significantly predictive of OS on multivariate analysis with a hazard ratio of 0.541 (95% confidence intervals, 0.312-0.937). Patients alive at follow-up had an average increase of 17.2% in cardiac SUVmean while patients that died had an average decrease in SUVmean decrease of 13.5% (P = .048). CONCLUSIONS: Our data demonstrated that posttreatment SUV changes in the heart were significant indicators of dose-response and predictors of OS. The present work is hypothesis generating and must be validated in an independent cohort. If validated, our data show the potential for cardiac metabolic changes to be an early predictor for clinical outcomes.
PURPOSE: Studies have noted a link between radiation dose to the heart and overall survival (OS) for patients with lung cancer treated with chemoradiation. The purpose of this study was to characterize pre- to posttreatment cardiac metabolic changes using fluorodeoxyglucose/positron emission tomography (FDG-PET) images and to evaluate whether changes in cardiac metabolism predict for OS. METHODS AND MATERIALS: Thirty-nine patients enrolled in a functional avoidance prospective study who had undergone pre- and postchemoradiation FDG-PET imaging were evaluated. For each patient, the pretreatment and posttreatment PET/CTs were rigidly registered to the planning CT, dose, and structure set. PET-based metabolic dose-response was assessed by comparing pretreatment to posttreatment mean standardized uptake values (SUVmean) in the heart as a function of dose-bin. OS analysis was performed by comparing SUVmean changes for patients who were alive or had died at last follow-up and by using a multivariate model to assess whether pre- to posttreatment SUVmean changes were a predictor of OS. RESULTS: The dose-response curve revealed increasing changes in SUV as a function of cardiac dose with an average SUVmean increase of 1.7% per 10 Gy. Patients were followed for a median of 437 days (range, 201-1131 days). SUVmean change was significantly predictive of OS on multivariate analysis with a hazard ratio of 0.541 (95% confidence intervals, 0.312-0.937). Patients alive at follow-up had an average increase of 17.2% in cardiac SUVmean while patients that died had an average decrease in SUVmean decrease of 13.5% (P = .048). CONCLUSIONS: Our data demonstrated that posttreatment SUV changes in the heart were significant indicators of dose-response and predictors of OS. The present work is hypothesis generating and must be validated in an independent cohort. If validated, our data show the potential for cardiac metabolic changes to be an early predictor for clinical outcomes.
Authors: Ellen X Huang; Andrew J Hope; Patricia E Lindsay; Marco Trovo; Issam El Naqa; Joseph O Deasy; Jeffrey D Bradley Journal: Acta Oncol Date: 2010-09-28 Impact factor: 4.089
Authors: Lisanne V van Dijk; Walter Noordzij; Charlotte L Brouwer; Ronald Boellaard; Johannes G M Burgerhof; Johannes A Langendijk; Nanna M Sijtsema; Roel J H M Steenbakkers Journal: Radiother Oncol Date: 2017-09-23 Impact factor: 6.280
Authors: Tina Wanting Zhang; Jonatan Snir; R Gabriel Boldt; George B Rodrigues; Alexander V Louie; Stewart Gaede; Ronald C McGarry; James J Urbanic; Megan E Daly; David A Palma Journal: Int J Radiat Oncol Biol Phys Date: 2019-01-07 Impact factor: 7.038
Authors: Justin P Hart; Matthew R McCurdy; Muthuveni Ezhil; Wei Wei; Meena Khan; Dershan Luo; Reginald F Munden; Valen E Johnson; Thomas M Guerrero Journal: Int J Radiat Oncol Biol Phys Date: 2008-05-19 Impact factor: 7.038
Authors: Matthew R McCurdy; Richard Castillo; Josue Martinez; Mohammad Najeeb Al Hallack; Jessica Lichter; Nicolas Zouain; Thomas Guerrero Journal: Radiother Oncol Date: 2012-05-10 Impact factor: 6.280
Authors: Frederika A van Nimwegen; Michael Schaapveld; David J Cutter; Cècile P M Janus; Augustinus D G Krol; Michael Hauptmann; Karen Kooijman; Judith Roesink; Richard van der Maazen; Sarah C Darby; Berthe M P Aleman; Flora E van Leeuwen Journal: J Clin Oncol Date: 2015-11-16 Impact factor: 44.544
Authors: Oi-Wai Chau; Ali Islam; Edward Yu; Melody Qu; John Butler; Heather Biernaski; Alexander Sun; Jean-Pierre Bissonnette; Anna MacDonald; Chantelle Graf; Aaron So; Gerald Wisenberg; Ting-Yim Lee; Frank S Prato; Stewart Gaede Journal: Adv Radiat Oncol Date: 2022-02-27